262 related articles for article (PubMed ID: 7543574)
1. Modification of the behavioral effects of (+/-)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys.
Rosenzweig-Lipson S; Barrett JE
J Pharmacol Exp Ther; 1995 Aug; 274(2):842-51. PubMed ID: 7543574
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects.
Schindler CW; Tella SR; Prada J; Goldberg SR
J Pharmacol Exp Ther; 1995 Feb; 272(2):791-8. PubMed ID: 7853196
[TBL] [Abstract][Full Text] [Related]
3. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
4. Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644.
Cohen C; Perrault G; Sanger DJ
Eur J Pharmacol; 1997 Oct; 336(2-3):113-21. PubMed ID: 9384222
[TBL] [Abstract][Full Text] [Related]
5. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
Usowicz MM; Gigg M; Jones LM; Cheung CW; Hartley SA
J Pharmacol Exp Ther; 1995 Nov; 275(2):638-45. PubMed ID: 7473149
[TBL] [Abstract][Full Text] [Related]
6. Bay K-8644 in different solvents acts as a transient calcium channel antagonist and a long-lasting calcium channel agonist.
Wu L; Wang R; Karpinski E; Pang PK
J Pharmacol Exp Ther; 1992 Mar; 260(3):966-73. PubMed ID: 1372052
[TBL] [Abstract][Full Text] [Related]
7. Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice.
Shin EJ; Nabeshima T; Lee PH; Kim WK; Ko KH; Jhoo JH; Jhoo WK; Cha JY; Kim HC
Behav Brain Res; 2004 May; 151(1-2):267-76. PubMed ID: 15084442
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
9. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.
Dubé GP; Baik YH; Schwartz A
J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcium channel ligands on anaesthetic properties of ethanol in mice.
Biała G
Pol J Pharmacol; 1999; 51(2):125-30. PubMed ID: 10425640
[TBL] [Abstract][Full Text] [Related]
11. Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels.
Saponara S; Sgaragli G; Fusi F
Eur J Pharmacol; 2008 Nov; 598(1-3):75-80. PubMed ID: 18789318
[TBL] [Abstract][Full Text] [Related]
12. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
Atchison WD
J Pharmacol Exp Ther; 1989 Nov; 251(2):672-8. PubMed ID: 2478694
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
Barrús MT; Reviriego J; Marín J
J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
[TBL] [Abstract][Full Text] [Related]
14. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
Motomura S; Hashimoto K; Hashimoto K
J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
[TBL] [Abstract][Full Text] [Related]
15. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of 5 calcium channel blockers on H2O2 release from mouse peritoneal macrophages].
Chen WR; Yang YX; Li DM; Zhang XY; Zheng HQ; Chen J
Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):379-81. PubMed ID: 7504391
[TBL] [Abstract][Full Text] [Related]
17. [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.
Sarmiento JG; Shrikhande AV; Janis RA; Triggle DJ
J Pharmacol Exp Ther; 1987 Apr; 241(1):140-6. PubMed ID: 2437286
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
Rampe D; Anderson B; Rapien-Pryor V; Li T; Dage RC
J Pharmacol Exp Ther; 1993 Jun; 265(3):1125-30. PubMed ID: 7685384
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcium antagonists on the cocaine- and methamphetamine-induced conditioned place preference.
Suzuki T; Shiozaki Y; Masukawa Y; Misawa M
Arukoru Kenkyuto Yakubutsu Ison; 1992 Feb; 27(1):81-90. PubMed ID: 1596245
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel antagonists suppress cross-tolerance to the anxiogenic effects of D-amphetamine and nicotine in the mouse elevated plus maze test.
Biala G; Kruk M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):54-61. PubMed ID: 17761379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
